Literature DB >> 25027938

Synthesis and receptor binding in trans-CD ring-fused A-CD estrogens: comparison with the cis-fused isomers.

Cristian Dabrota1, Muhammad Asim1, Christine Choueiri1, Ana Gargaun1, Ilia Korobkov1, Ammara Butt1, Kathryn E Carlson2, John A Katzenellenbogen2, James S Wright3, Tony Durst4.   

Abstract

Ligands which selectively activate only one of the estrogen receptors, ERα or ERβ, are current pharmaceutical targets. Previously, we have reported on substituted cis A-CD ligands in which the B-ring of the steroidal structure has been removed and cis refers the stereochemistry of the CD ring junction as compared to trans in estradiol. These compounds often showed good potency and selectivity for ERβ. Here we report the synthesis and binding affinities for a similar series of trans A-CD ligands, and compare them to the cis-series. Counterintuitively, trans A-CD ligands, which are structurally more closely related to the natural ligand estradiol, show weaker binding and less β-selectivity than their cis-counterparts.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ERα; ERβ; Estrogen receptor; Ligand synthesis; β-Selectivity

Mesh:

Substances:

Year:  2014        PMID: 25027938      PMCID: PMC4249688          DOI: 10.1016/j.bmcl.2014.06.066

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Deconstructing estradiol: removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists.

Authors:  Muhammad Asim; Mohammud Asim; Mohamed El-Salfiti; Yiming Qian; Christine Choueiri; Samira Salari; James Cheng; Hooman Shadnia; Manpartap Bal; M A Christine Pratt; Kathryn E Carlson; John A Katzenellenbogen; James S Wright; Tony Durst
Journal:  Bioorg Med Chem Lett       Date:  2008-12-24       Impact factor: 2.823

2.  Experimental versus predicted affinities for ligand binding to estrogen receptor: iterative selection and rescoring of docked poses systematically improves the correlation.

Authors:  James S Wright; James M Anderson; Hooman Shadnia; Tony Durst; John A Katzenellenbogen
Journal:  J Comput Aided Mol Des       Date:  2013-08-24       Impact factor: 3.686

3.  Total syntheses of optically active 19-norsteroids. (+)-Estr-4-ene-3,17-dione and (+)13 beta-ethylgon-4-ene-3,17-dione.

Authors:  R A Micheli; Z G Hajos; N Cohen; D R Parrish; L A Portland; W Sciamanna; M A Scott; P A Wehrli
Journal:  J Org Chem       Date:  1975-03-21       Impact factor: 4.354

4.  The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.

Authors:  Muhammad Zahid; Ekta Kohli; Muhammad Saeed; Eleanor Rogan; Ercole Cavalieri
Journal:  Chem Res Toxicol       Date:  2006-01       Impact factor: 3.739

5.  A-CD estrogens. I. Substituent effects, hormone potency, and receptor subtype selectivity in a new family of flexible estrogenic compounds.

Authors:  James S Wright; Hooman Shadnia; James M Anderson; Tony Durst; Muhammad Asim; Mohamed El-Salfiti; Christine Choueiri; M A Christine Pratt; Samantha C Ruddy; Rosanna Lau; Kathryn E Carlson; John A Katzenellenbogen; Peter J O'Brien; Luke Wan
Journal:  J Med Chem       Date:  2010-12-29       Impact factor: 7.446

Review 6.  Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism.

Authors:  E L Cavalieri; E G Rogan; D Chakravarti
Journal:  Cell Mol Life Sci       Date:  2002-04       Impact factor: 9.261

7.  Thiophene-core estrogen receptor ligands having superagonist activity.

Authors:  Jian Min; Pengcheng Wang; Sathish Srinivasan; Jerome C Nwachukwu; Pu Guo; Minjian Huang; Kathryn E Carlson; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  J Med Chem       Date:  2013-04-15       Impact factor: 7.446

Review 8.  Estrogen receptor β ligands: recent advances and biomedical applications.

Authors:  Filippo Minutolo; Marco Macchia; Benita S Katzenellenbogen; John A Katzenellenbogen
Journal:  Med Res Rev       Date:  2011-05       Impact factor: 12.944

9.  Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.

Authors:  Kai-Ming Li; Rosa Todorovic; Prabu Devanesan; Sheila Higginbotham; Harald Köfeler; Ragulan Ramanathan; Michael L Gross; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Carcinogenesis       Date:  2003-10-24       Impact factor: 4.944

10.  Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

Authors:  Anders Ström; Johan Hartman; James S Foster; Silke Kietz; Jay Wimalasena; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

  10 in total
  1 in total

1.  A-C Estrogens as Potent and Selective Estrogen Receptor-Beta Agonists (SERBAs) to Enhance Memory Consolidation under Low-Estrogen Conditions.

Authors:  Alicia M Hanson; K L Iresha Sampathi Perera; Jaekyoon Kim; Rajesh K Pandey; Noreena Sweeney; Xingyun Lu; Andrea Imhoff; Alexander Craig Mackinnon; Adam J Wargolet; Rochelle M Van Hart; Karyn M Frick; William A Donaldson; Daniel S Sem
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.